✦ LIBER ✦

[123] SUSTAINED VIROLOGICAL RESPONSE RATES WITH PEGINTERFERON a-2a (40 kD) (PEGASYS®) PLUS RIBAVIRIN (COPEGUS®) IN RANDOMISED CONTROLLED CLINICAL TRIALS ARE REPLICATED IN THE CLINICAL PRACTICE SETTING

✍ Scribed by A. Alberti; E. Zehnter; S.S. Lee; S.J. Hadziyannis; S. Zeuzem; M. Rizzetto; M. Diago

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.238 High sustained virological respons

✍ M. Rendina; A. Schena; N.M. Castellaneta; F. Losito; A.C. Amoruso; G. Stallone; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 144 KB

P.411 The impact of age on sustained vir

✍ J. Rockstroh; F.J. Torriani; M. Rodriguez Torres; E. Lissen; A. Lazzarin; J. De 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 274 KB

O.161 High SVR rates with 24 weeks of pe

✍ P. Ferenci; T. Scherzer; H. Laferl; K. Staufer; A. Maieron; M. Gschwantler; H. B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 140 KB

567 Peginterferon alpha-2a (40KD) (PEGAS

✍ M. Diago; R. Sola; A. Olveira; M. Romero-Gomez; R. Planas; R. Moreno; R. Perez; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

507 Early prediction of sustained virolo

✍ M. Rodriguez-Torres; F.J. Torriani; E. Lissen; N. Brau; M. Sulkowski; R. Sola; B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

522 Combination therapy with peginterfer

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB